| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 12.88 | 13.3% | 12.1% |
| Total Income | 12.88 | 13.3% | 12.1% |
| Expenditure | 13.71 | 1.7% | 9.3% |
| PBT | -1.88 | 49.0% | 59.7% |
| Net Profit | -1.98 | 47.6% | 57.9% |
| OPM | -6.46% | 16.17pp | 25.18pp |
| NPM | -15.41% | 17.81pp | 25.54pp |
| EPS | -0.05 | 44.4% | 64.3% |
Apyx Medical Reports Q3 2025 Results
04 May 2026 · 4 May, 7:51 am
Summary
Apyx Medical Corporation issued a press release on November 6, 2025, reporting its results of operations for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference. The information is furnished under Item 2.02 of Form 8-K.
Key Highlights
- 1
Apyx Medical Corporation reported its results of operations for the third quarter ended September 30, 2025.
- 2
The press release was issued on November 6, 2025.
- 3
The information is furnished under Item 2.02 of Form 8-K.
Informational and educational content only. Not investment advice.